TOP TIERMARKET NEWSWIRE
News & sentiment

NRX PHARMACEUTICALS (NRXP) — News & AI sentiment

NRX PHARMACEUTICALS (NRXP) news roundup. 8 stories aggregated over the last 30 days. Average 30-day sentiment is 61.9/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
8
avg sentiment 61.9/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

NRXP news in the last 24 hours, 7 days, 30 days and 90 days

How much NRXP coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowNRXP storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days0—no coverage
Last 30 days861.9/100NRXP headlines →
Last 90 days2957.3/100NRXP headlines →

Latest stories on NRXP

Oct 19
Oct 19
Oct 16
Oct 15
Oct 5
NRx Defense Systems awarded $11M DARPA prime contract
Seeking Alpha71 · bullishproduct/pr
Sep 30
Sep 30
Sep 30
Sep 16
Sep 15
Sep 14
Sep 14
Sep 14
Sep 14
Sep 11
Sep 8
Sep 8
Aug 18
Aug 18
Aug 17
Aug 17
Aug 17
Aug 17
Aug 10
H.C. Wainwright reiterates NRx Pharmaceuticals stock rating at buy
Investing.com Analyst Ratings61 · neutralanalyst
Aug 10
Open NRXP in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →